Navidea Biopharmaceuticals Inc Beta
Что обозначает Beta в Navidea Biopharmaceuticals Inc?
Beta Navidea Biopharmaceuticals Inc является 0.00
Какое определение для Beta?
БЕТА показывает, если акция является более или менее волатильной, чем рынок в целом. Бета меньше 1 указывает на то, что акции менее волатильные, чем рынок, а бета больше 1 указывает на то, что акции более волатильные. Волатильность измеряется как колебание цены вокруг среднего значения.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta компаний в Health Care сектор на NYSEMKT по сравнению с Navidea Biopharmaceuticals Inc
Что делает Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Компании с beta похож на Navidea Biopharmaceuticals Inc
- Vision Marine Technologies имеет Beta из 0.00
- Ely Gold Royalties имеет Beta из 0.00
- Glacier Lake Resources имеет Beta из 0.00
- Magnum Mining and Exploration имеет Beta из 0.00
- Africa Opportunity Fund имеет Beta из 0.00
- Fulcrum Utility Services имеет Beta из 0.00
- Navidea Biopharmaceuticals Inc имеет Beta из 0.00
- Gullewa имеет Beta из 0.00
- S.A.L. Steel имеет Beta из 0.00
- Andina Acquisition III имеет Beta из 0.00
- Andina Acquisition III имеет Beta из 0.00
- Brilliant Acquisition имеет Beta из 0.00
- Indokem имеет Beta из 0.00